James R. Sowers

Active 1976–2024

203
Papers
46,339
Citations
116
h-index
202
i10-index

Citations

Citations per year for James R. Sowers1976: 1 citations1977: 6 citations1978: 3 citations1979: 2 citations1980: 3 citations1981: 5 citations1982: 15 citations1983: 20 citations1984: 15 citations1985: 13 citations1986: 13 citations1987: 14 citations1988: 13 citations1989: 21 citations1990: 16 citations1991: 21 citations1992: 15 citations1993: 23 citations1994: 35 citations1995: 37 citations1996: 35 citations1997: 45 citations1998: 63 citations1999: 89 citations2000: 90 citations2001: 126 citations2002: 161 citations2003: 201 citations2004: 300 citations2005: 266 citations2006: 240 citations2007: 283 citations2008: 258 citations2009: 255 citations2010: 293 citations2011: 280 citations2012: 330 citations2013: 259 citations2014: 317 citations2015: 327 citations2016: 253 citations2017: 308 citations2018: 305 citations2019: 1,066 citations2020: 1,240 citations2021: 1,341 citations2022: 1,211 citations2023: 1,065 citations2024: 1,649 citations2025: 840 citations2026: 31 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,938 citing papers, 24% of this breakdownChina: 2,768 citing papers, 16.9% of this breakdownUnited Kingdom: 822 citing papers, 5% of this breakdownItaly: 791 citing papers, 4.8% of this breakdownCanada: 551 citing papers, 3.4% of this breakdownGermany: 535 citing papers, 3.3% of this breakdownAustralia: 474 citing papers, 2.9% of this breakdownJapan: 412 citing papers, 2.5% of this breakdownSpain: 385 citing papers, 2.3% of this breakdownIndia: 380 citing papers, 2.3% of this breakdownFrance: 353 citing papers, 2.1% of this breakdownSouth Korea: 306 citing papers, 1.9% of this breakdown
0%24%Other 28.6%

Fields

  • Medicine71.3%
  • Biochemistry, Genetics and Molecular Biology18.5%
  • Neuroscience2.5%
  • Nursing1.9%
  • Immunology and Microbiology1.5%
  • Agricultural and Biological Sciences0.7%
  • Other3.6%

Topics

  • Cardiovascular Function and Risk Factors3.7%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.9%
  • Adipose Tissue and Metabolism2.9%
  • Diabetes Treatment and Management2.7%
  • Adipokines, Inflammation, and Metabolic Diseases2.3%
  • Blood Pressure and Hypertension Studies2.2%
  • Other83.3%

Coauthors

All papers

Open in search
  1. Insulin resistance, cardiovascular stiffening and cardiovascular disease

    Authors: , , , , , , - Metabolism 2021 cited by 1,028

  2. Diabetic Cardiomyopathy

    Authors: , , - Circulation Research 2018 cited by 1,791

  3. Obesity, Adipose Tissue and Vascular Dysfunction

    Authors: , , , - Circulation Research 2021 cited by 848

  4. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases

    Authors: , , , , - Nature Reviews Cardiology 2021 cited by 707

  5. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease

    Authors: , , - Diabetologia 2017 cited by 881

  6. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

    Authors: , , - Nature Reviews Endocrinology 2015 cited by 966

  7. Role of Mitochondrial Dysfunction in Insulin Resistance

    Authors: , , - Circulation Research 2008 cited by 1,109

  8. Endothelial cell senescence in aging-related vascular dysfunction

    Authors: , , , - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018 cited by 441

  9. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications

    Authors: , , , , - Physiological Reviews 2021 cited by 365

  10. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease

    Authors: , - Hypertension 2021 cited by 409

  11. Role of insulin resistance in endothelial dysfunction

    Authors: , - Reviews in Endocrine and Metabolic Disorders 2013 cited by 516

  12. FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis

    Authors: , , , , , , , , , , , , , , - Metabolism 2021 cited by 153

  13. Insulin and insulin resistance:

    Authors: , - Medical Clinics of North America 2004 cited by 1,540

  14. Fibroblast Growth Factor 23 and Hypophosphatemia: A Case of Hypophosphatemia along the Rickets-Osteomalacia Spectrum

    Authors: , , , - Cardiorenal Medicine 2016 cited by 682

  15. The pathophysiology of hypertension in patients with obesity

    Authors: , , - Nature Reviews Endocrinology 2014 cited by 553

  16. Obesity‐Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment

    Authors: , , , , , , - Journal of Clinical Hypertension 2012 cited by 524

  17. Insulin Resistance and Heart Failure

    Authors: , , - Heart Failure Clinics 2012 cited by 254

  18. Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights

    Authors: , , , , , , , - International Journal of Molecular Sciences 2024 cited by 97

  19. Targeting autophagy in obesity: from pathophysiology to management

    Authors: , , - Nature Reviews Endocrinology 2018 cited by 334

  20. Diabetes, Hypertension, and Cardiovascular Disease

    Authors: , , - Hypertension 2001 cited by 1,345

  21. Cell death regulation by MAMs: from molecular mechanisms to therapeutic implications in cardiovascular diseases

    Authors: , , , - Cell Death and Disease 2022 cited by 76

  22. Diabetes and Cardiovascular Disease

    Authors: , , , , , , , , - Circulation 1999 cited by 2,697

  23. FUNDC1 interacts with FBXL2 to govern mitochondrial integrity and cardiac function through an IP3R3-dependent manner in obesity

    Authors: , , , , , , , - Science Advances 2020 cited by 133

  24. Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics

    Authors: , , , , , , , - Journal of Molecular Cell Biology 2022 cited by 73